Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ralph Corey
Martin E Stryjewski

Showing results (1-10 of 194) with videos related to

Pageof 20
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2013
Methicillin-resistant Staphylococcus aureus: an evolving pathogenMartin E Stryjewski, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2011
New rules for clinical trials of patients with acute bacterial skin and skin-structure infections: do not let the perfect be the enemy of the goodG Ralph Corey, Martin E Stryjewski
Current Opinion in Critical Care|June 30, 2009
New treatments for methicillin-resistant Staphylococcus aureusMartin E Stryjewski, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 10, 2015
Reply to SolnickG Ralph Corey, Martin E Stryjewski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2014
Editorial commentary: NOVA score to predict endocarditis in patients with enterococcal bacteremia: sticking to valves or to scores?Martin E Stryjewski, G Ralph Corey
Future Microbiology|March 10, 2010
Telavancin's interactions with the bacterial cell membraneEsteban C Nannini, Martin E Stryjewski, G Ralph Corey
Diagnostic Microbiology and Infectious Disease|January 14, 2015
Ceftaroline: clinical and microbiology experience with focus on methicillin-resistant Staphylococcus aureus after regulatory approval in the USAMartin E Stryjewski, Ronald N Jones, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2015
Reply to DiNubileG Ralph Corey, Helen W Boucher, Martin E Stryjewski
Expert Opinion on Pharmacotherapy|April 21, 2010
Ceftaroline for complicated skin and skin-structure infectionsEsteban C Nannini, Martin E Stryjewski, G Ralph Corey
International Journal of Antimicrobial Agents|November 26, 2009
Short-course therapy for bloodstream infections in immunocompetent adultsG Ralph Corey, Martin E Stryjewski, Richard J Everts
Pageof 20

Showing results (1-10 of 194) with videos related to

Sort By:
Pageof 20
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2013
Methicillin-resistant Staphylococcus aureus: an evolving pathogenMartin E Stryjewski, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2011
New rules for clinical trials of patients with acute bacterial skin and skin-structure infections: do not let the perfect be the enemy of the goodG Ralph Corey, Martin E Stryjewski
Current Opinion in Critical Care|June 30, 2009
New treatments for methicillin-resistant Staphylococcus aureusMartin E Stryjewski, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 10, 2015
Reply to SolnickG Ralph Corey, Martin E Stryjewski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2014
Editorial commentary: NOVA score to predict endocarditis in patients with enterococcal bacteremia: sticking to valves or to scores?Martin E Stryjewski, G Ralph Corey
Future Microbiology|March 10, 2010
Telavancin's interactions with the bacterial cell membraneEsteban C Nannini, Martin E Stryjewski, G Ralph Corey
Diagnostic Microbiology and Infectious Disease|January 14, 2015
Ceftaroline: clinical and microbiology experience with focus on methicillin-resistant Staphylococcus aureus after regulatory approval in the USAMartin E Stryjewski, Ronald N Jones, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2015
Reply to DiNubileG Ralph Corey, Helen W Boucher, Martin E Stryjewski
Expert Opinion on Pharmacotherapy|April 21, 2010
Ceftaroline for complicated skin and skin-structure infectionsEsteban C Nannini, Martin E Stryjewski, G Ralph Corey
International Journal of Antimicrobial Agents|November 26, 2009
Short-course therapy for bloodstream infections in immunocompetent adultsG Ralph Corey, Martin E Stryjewski, Richard J Everts
Pageof 20